Family offices have become an important source of long-duration private capital. Deloitte estimates that 8,030 single-family offices manage US$3.1 trillion, with assets under management expected to reach US$5.4 trillion by 2030. UBS’s 2026 survey of 307 family offices found average managed assets of US$1.3 billion. Such multigenerational capital can support strategic opportunities whose development periods do not fit conventional fund timelines. Deloitte, UBS
Patient Capital is therefore not capital from a Vaana-managed fund. We work with family offices pursuing long-term strategic investments and with institutional investors positioned to underwrite enduring themes. Our geographic focus is India, the European Union and Switzerland, where structural shifts in technology, energy, financial services, industrial capability and cross-border trade are creating opportunities that may require time, networks and active strategic support.
We help originate and evaluate opportunities, align investors with company leadership and shape transaction structures. For fast-growing portfolio or group companies facing a financing gap, we can seek special-situations structured capital, including solutions for expansion, acquisitions, shareholder transitions or timing mismatches.
Our role combines strategic advice, transaction execution and capital relationships. Each mandate remains subject to investor approval, diligence, regulation and definitive documentation; Vaana does not represent that it manages pooled Patient Capital of its own.